How to buy Lexicon Pharmaceuticals stock (LXRX)

Lexicon Pharmaceuticals is a biotechnology business based in the US. Lexicon Pharmaceuticals shares (LXRX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.71 – a decrease of 11.8% over the previous week. Lexicon Pharmaceuticals employs 285 staff and has a trailing 12-month revenue of around $5.2 million.

Our top picks for where to buy Lexicon Pharmaceuticals stock

Buy Lexicon Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Lexicon Pharmaceuticals stock price (NASDAQ: LXRX)

Use our graph to track the performance of LXRX stocks over time.

Lexicon Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.71
52-week range	$0.62 - $3.73
50-day moving average more info button	$1.26
200-day moving average more info button	$1.70
Wall St. target price	$3.60
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.74

Is it a good time to buy Lexicon Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lexicon Pharmaceuticals price performance over time

Historical closes compared with the close of $0.7147 from 2024-12-20

1 week (2024-12-13)	-11.80%
1 month (2024-11-22)	-17.22%
3 months (2024-09-20)	-56.95%
6 months (2024-06-21)	-61.37%

1 year (2023-12-22)	-45.44%
2 years (2022-12-22)	-63.35%
3 years (2021-12-22)	4.2
5 years (2019-12-20)	4.41

Lexicon Pharmaceuticals financials

Revenue TTM	$5.2 million
Gross profit TTM	$-52,677,000
Return on assets TTM	-44.16%
Return on equity TTM	-136.09%
Profit margin	0%
Book value	$0.49
Market Capitalization more info button	$244.8 million

TTM: trailing 12 months

Lexicon Pharmaceuticals share dividends

We're not expecting Lexicon Pharmaceuticals to pay a dividend over the next 12 months.

Have Lexicon Pharmaceuticals's shares ever split?

Lexicon Pharmaceuticals's shares were split on a 1:7 basis on 20 May 2015 . So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexicon Pharmaceuticals shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Lexicon Pharmaceuticals shares which in turn could have impacted Lexicon Pharmaceuticals's share price.

Lexicon Pharmaceuticals share price volatility

Over the last 12 months, Lexicon Pharmaceuticals's shares have ranged in value from as little as $0.6204 up to $3.73. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexicon Pharmaceuticals's is 1.244. This would suggest that Lexicon Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Lexicon Pharmaceuticals overview

Lexicon Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas. .

Frequently asked questions

What percentage of Lexicon Pharmaceuticals is owned by insiders or institutions?
Currently 1.148% of Lexicon Pharmaceuticals shares are held by insiders and 83.095% by institutions. How many people work for Lexicon Pharmaceuticals?
Latest data suggests 285 work at Lexicon Pharmaceuticals. When does the fiscal year end for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals's fiscal year ends in December. Where is Lexicon Pharmaceuticals based?
Lexicon Pharmaceuticals's address is: 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 What is Lexicon Pharmaceuticals's ISIN number?
Lexicon Pharmaceuticals's international securities identification number is: US5288723027 What is Lexicon Pharmaceuticals's CUSIP number?
Lexicon Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 528872104